Table 1.
Patient characteristics.
| Variable | n (%) |
|---|---|
| Gender (n = 275) | |
| Male | 174 (63.3) |
| Female | 101 (36.7) |
| Race (n = 274) | |
| White | 150 (54.7) |
| African American | 101 (36.9) |
| Other | 23 (8.4) |
| Kidney transplantation (n = 274) | 36 (13.1) |
| Cause of ESRD (n = 274) | |
| Type 1 diabetes mellitus | 7 (2.6) |
| Type 2 diabetes mellitus | 47 (17.2) |
| GN | 39 (14.2) |
| Secondary GN/vasculitis | 5 (1.8) |
| Interstitial nephritis | 3 (1.1) |
| Hypertension | 88 (32.1) |
| Cystic/congenital/hereditary | 35 (12.8) |
| Neoplasms | 2 (0.7) |
| Other | 48 (17.5) |
| Medical historya | |
| Myocardial infarction | 24 (8.8) |
| Ischemic heart disease | 53 (19.4) |
| Cardiac arrest | 6 (2.2) |
| Cardiac dysrhythmia | 33 (12.0) |
| Pericarditis | 2 (0.7) |
| Peripheral vascular disease | 26 (9.5) |
| Cerebrovascular disease | 22 (8.0) |
| COPD | 21 (7.7) |
| Malignant neoplasm | 29 (10.6) |
| Diabetes mellitus (type 1 or 2) | 74 (27.2) |
| Hypertension | 228 (83.2) |
| Alcohol or drug dependence | 5 (1.8) |
| Tobacco use | 26 (9.5) |
a
Several subjects had missing medical history, but the sample size was at least 272 in all categories.
COPD, chronic obstructive pulmonary disease; ESRD, end-stage renal disease; GN, glomerulonephritis.